Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Celgene and NCI collaborate on thalidomide cancer trial

April 6, 1999

Noncardiotoxic anthracyclines disclosed by Gem

April 6, 1999

Phase II trials of first anticancer dioxolane nucleoside analogue begin

April 5, 1999

Aronex regains worldwide marketing rights to Atragen

April 1, 1999

Dihydropyridines for reversing MDR presented at Japanese scientific meeting this week

April 1, 1999

Protein farnesyltransferase inhibitors emerge from Schering-Plough/Pharmacopeia collaboration

April 1, 1999

New microtubule-stabilizing agents developed at Schering

April 1, 1999

New microbially produced inhibitor of HSP expression in development at Mercian

April 1, 1999

O6-Benzylguanine shows potential for oral efficacy in humans

March 31, 1999

Studies on BTK inhibitors expected to result in discovery of new anticancer drugs

March 31, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...